Rocket Pharmaceuticals Inc at UBS Global Healthcare Conference Transcript
Well, good morning, everyone, and welcome to day 2 of the UBS Global Healthcare Conference. It is my pleasure to host Rocket Pharmaceuticals here today. From the company, we have Gaurav Shah, the CEO. If anyone has a question, there's a QR code, you can scan it. And all being well, the question should pop up on the iPad here, and I can field it for you.
I think -- Gaurav, I'm sure you have a few sort of opening remarks, especially with the positive data recently. So I'll turn it over to you, and then we can dig into some questions.
Thanks, Colin, for having us here, at the UBS. Good to see everybody. Not very often we come back to live conferences, so this feels really good. So Rocket Pharma, we're a gene therapy company. We're a multi-platform or platform agnostic, depending on how you think about it. And we have 2 platforms. One is an in vivo AAV platform. Right now, we apply to a cardiology disease called Danon
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
